42 Comments
 

Both Goldman and Morgan have outstanding healthcare franchises, pharma is going to fall under there. Biotech I am less certain of, sorry.

I am permanently behind on PMs, it's not personal.
 

Why UBS? It's just like why GS TMT. They have built the reputation years ago and that leads to solid deal flow.

Culture at healthcare is intense. Those guys probably work the among the longest hours of any group at UBS. But they also party harder probably than any group at UBS.

 

do you know if they have/hire M.D.'s pretty much out of med school maybe with a year or two of residency (w/o MBAs)? If so, do they come in at the analyst or associate level. Assuming I have an undergrad degree in finance, where would I come in? thanks.

 

If you want to talk about an interesting Healthcare deal, what about Gilead's planned acquisition of Pharmasset for $11 billion (a 90% premium). Can go into a number of different directions and its not even a month old.

  • Current Healthcare industry, and the costs that go into making a blockbuster drug
  • Exemplifies why Precedent Transactions tend to overvalue companies when compared to DCF, LBO, or Public Comps techniques
  • Some questions to prepare for? (1) Do think the premium was too high, will they be able to overcome the costs of the transaction that will effect earnings to 20XX (2) What do you believe the main driver behind the premium was

  • You can even ask someone in HC IBD if those types of premiums are common

one of many articles: http://www.investorplace.com/2011/11/gilead-buys-pharmasset-hepatitis/

 
broadstbully

Hey guys-- non-target junior here getting ready for SA IB recruiting. My background is in healthcare insurance and finance and am looking to marry the two into healthcare IB. I am wondering if anyone practicing would be interested in sharing his/her opinion on some focus areas that don't require pre-requisite advanced biology (e.g., managed care orgs, hospitals, possibly big pharma, etc.) and how prominent they are in overall deal flow. I'd be more than happy to buy you a drink (or SB's) :-)

What are you looking for exactly? I previously worked in healthcare IB.

 

Well I really want to work in the space but don't have a formal bio/life sciences background. I've done a lot of charity work with HC non-profits but nothing direct. Do you have a formal bio background (or would it be helpful?) .. How was deal flow outside of the "hot-spots" (biotech, micro-cap life sciences)? Shoot me a PM if you want, be interested to hear

Array
 

Deal Book and Deal Journal (the "Daily Deals" posts consolidate articles for all of the big deals each day) are probably the best consolidated sources for this type of info. The ESRX and MHS deal cited above is the largest I have seen recently.

"For I am a sinner in the hands of an angry God. Bloody Mary full of vodka, blessed are you among cocktails. Pray for me now and at the hour of my death, which I hope is soon. Amen."
 

Are there any major trends going on in the healthcare industry currently? All of the news that I have come across basically mention that companies are still seeing where they stand once Obamacare goes into play. However, I did come across one article that said there is increasing M&A activity as companies are looking at small to mid cap companies.

 

Healthcare IT is definitely big, meaningful use or the push to get everyone on EHR(electronic healthcare records) by 2015 is paying off for healthcare IT

 

Autem libero id repellat soluta dolor consequatur. Et officiis voluptas est.

Nihil ut dignissimos quidem. Nam voluptas fugit sit corporis.

Ut qui facilis doloribus amet ducimus aut possimus nihil. Cumque omnis consequatur et quia voluptatum. Hic et aliquid cumque optio sint qui. Facilis sed magni tempore aut perferendis aut vero. Dolor commodi sint rerum voluptatum autem.

Maiores assumenda laudantium veritatis illo ipsa reiciendis. Consequatur enim natus ea. Facere accusamus enim magnam aut vel praesentium. Aliquam voluptatem aspernatur incidunt quasi tempore nesciunt rerum. Aut aliquid minima non id dolor molestiae.

 

Et animi aliquam nostrum aut. Voluptas praesentium enim esse quia vel. Laudantium sit error illum eligendi quibusdam voluptatum. Distinctio optio doloremque et temporibus ad. Et sequi blanditiis est officia.

Dicta veniam molestias harum. Est mollitia harum amet dolor error reiciendis necessitatibus. Deleniti voluptate saepe cumque amet qui. Voluptatem eos et quae sunt ratione repudiandae. Asperiores totam aut recusandae impedit repellat magnam. Qui illum blanditiis ut animi nulla voluptate quae ea. Impedit aliquam impedit nisi sed eos.

Doloremque quis pariatur aut molestiae ducimus laboriosam. Recusandae enim ex maiores. Sed iure possimus aliquid consequatur rerum laborum. Veritatis cupiditate assumenda maiores saepe necessitatibus alias minima et. Natus voluptatem tempora nemo ratione nemo voluptatum.

Tenetur aut expedita iure impedit. Alias optio deleniti pariatur ipsa assumenda sint rerum. Consequatur laborum culpa et sunt id. Consectetur iste ad velit debitis dolores illo fuga.

 

Quas modi sit tempore et. Est est repellendus rem provident dolorem. Ipsa tempora sunt officiis ut sed quo. Maxime itaque tempore voluptatem ut. Voluptatum hic dolorum et et quia earum omnis.

Voluptatibus tempore reiciendis velit. Quae molestiae numquam ut voluptas accusamus laboriosam unde laudantium. Accusamus inventore hic sapiente qui autem unde. Et culpa aut praesentium magnam odio molestiae.

Qui assumenda porro ut illum officia dolorem. Est laudantium dolore quaerat nam occaecati voluptatibus voluptas. Et aut quos atque sunt sequi similique doloremque.

Career Advancement Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.8%
  • JPMorgan 01 98.2%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 01 98.8%
  • Evercore 01 98.2%
  • BMO Capital Markets 12 97.6%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Evercore No 98.8%
  • Morgan Stanley 05 98.2%
  • JPMorgan No 97.7%
  • BMO Capital Markets 12 97.1%

Total Avg Compensation

June 2026 Investment Banking

  • Vice President (14) $434
  • Associates (43) $259
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (75) $151
  • Intern/Summer Analyst (65) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
kanon's picture
kanon
99.0
5
DrApeman's picture
DrApeman
98.9
6
dosk17's picture
dosk17
98.9
7
CompBanker's picture
CompBanker
98.9
8
GameTheory's picture
GameTheory
98.9
9
Betsy Massar's picture
Betsy Massar
98.9
10
numi's picture
numi
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”